Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ike, am a long (and added more shares on May 10) but I agree with your remarks fully. I was not too crazy about the idea of delaying a positive TLD until Journal publication. But I went along with it assuming they knew more about the possible short attack without the support of the Journal article. So when NYAS presentation became possible why did they depart from their plan and go forward despite the issues with LL and no cooperation from FINRA on halting trading. All the pain of the last 18 months were for naught! WHY? What moved them to depart from plan? At the ASM, LP will need to answer for this!
I still believe in the science as May 10 presentation showed. We will get approved but the path may be a bit more tortuous than I expected.
But I think the slide set were published at the start of his talk.
Ex, what that tells me, is that recurrent GBM (90% of whom received DCVAX) responds even better to DCVAX than does ndGBM (early vaccine). But the response in the latter is very much an improvement for bdGBM and certainly worthy of approval. The key point here is the positive response in the recurrent GBM is itself due to DCVAX as well, and not a comparison of "placebo only" cohort but is due to their (90%) treatment with DCVAX.
I very much agree. They should have released this datq in a much larger forum, and most impotantly one with a Q&A period after, attended by the top journalists in the field so that they could respond to questions and explain why this is a great result and deflate the arguments of the naysayers with the hard data! Today, should not have happened in the format that it did!
That was confounded by the pseudo results caused by the vaccine.
I just bought another 50K shares. I never thought I would get them this cheap ever again!
You have got to wonder WHY they will not put the presentation slides on the NWBO website as well -- WHY NOT?
I think the fudsters hit it hard because they had a little bit of news that can be seen as bad with the news that LL was sick (or "sick" if want to be more cynical) and someone else was presented - so they hopped on iy hard and brought it to $1.20 at its low). We will have to see what happens when the presentation (with the "same data") is made by someone else.
Is LL no longer giving the presentation??
Session 6: Unique Challenges in Emerging Immunotherapies (Continued)
11:10 AM-12:10 PM
11:10 AM
Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma
Paul Mulholland, MBBS, MSc, PhD, FRCP, University College Hospital *
11:40 AM
So if you are LP and have already decided that this LL presentation is the right time to release the TLD, when exactly do you do it for maximum effect? Do you release it yesterday after the close (which did not happen), or do you release it early morning today, say 6:30 AM so it can be absorbed by the market ( which also did not happen), or do you release it around now at 8:30 to 9:00 AM or do you release at about the open, or do you wait to release right around the presentation time? Decisions, decisions ..... Any market mavenim care to comment?
More likely it is the capping action of those interests that have an interest that this stock not rise.
HI, to all,
I missed the post by MID that everyone is raving about. But I see that this message has been deleted for some reason. Can someone please repost the message sans what got it deleted. thanx
I remember it well. I was in Dendreon and made some good money - but could have made more if my timing had been better.
Sorry Senti, but when an admittance fee is required to gain entry to the presentation, that should not qualify as full public disclosure - it is only being disclosed to those few who pay the fee to gain admittance.
Almost perfect call Sojo. At the last second before close they dropped it by a half penny to #1.625 -- congrats on that call.
Thanks for the response, but I am not sure I am understanding correctly. To simplify, if our universe (at OTC) consists of three MMs, A, B and C and all the investors who can only place orders through them. Then each of A, B and C have a computer they are in contol of that takes the orders from their clients, The MMs get to show what they please on their computer of the orders they get in. Then there is a computer from the "OTC" (ie those in charge of what the investing public sees) that queries the computers of A, B and C for their respective bid/ask and then OBJECTIVELY publishes in real time the highest bid/lowest ask for us to see that we all know as the bid/ask.. When you say "the inside" you mean what exactly?
That is not what I was asking about. It is the investor placing the bid who decides if it will be and iceberg order or not.
Do any of the cognoscenti on the board know who is in charge of what we see when we check the bid/ask in real time on the OTC? Is there ant monkey business going on behind the curtains in what we are allowed to see? Are MMs (or some other) in charge of this and do they get to show us only what they want or is there some objective computer using a well known algorithm that spews out the bid/ask as it comes in from investors? Do many bid/ask's never show up in what we see as the "broadcast" bis/ask to us but only eventually show up if an actual transaction occurs?
I am sorry to hear about your circumstances.
Hi Sojo, I'll take parabolic, but I would rather have HYPERbolic or better yet exponential. ;Short term is looking rosy - long term never in doubt.
So perhaps some 2M of the legit short covered today and some new investors rushing to hop on the departing train -- that leaves some 23M shares left to cover PLUS who knows how many naked shorts.
You too, Hoffy
we don't know if there has been a delay.
I recently read that the NIH looked at all the completed Phase 3 trials and found that something like 30% of trials hadn't been reported on 4 years after they completed.
I believe we’ll see TLD/journal article between 5/26-6/2, to coincide with the full text of the ASCO abstract. This timing will allow the SP to achieve a higher base before TLD.
Well put PM.
I know for a fact that the caution they are taking with the external controls are that they are validating the external controls against previous failed trials to confirm the consistency and validity of their results.
My OPINION is that NWBO had enough data to know that the secondary OS failed, so went to external controls.
I could care less about those endpoints. They are clearly post hoc even if implemented prior to datalock.
That is a cool stat. Thanks for that. It certainly show a tremendous amount of interest. If only LP would get off the pot and ....
Yup, it is a snapshot chart of the history produced by the many buyers and sellers, but with NWBO it is now clear that the future price movement of NWBO is totally dependent on the whims, timing and actions of one mind only - that of LP - and the news she chooses to announce or withhold. All the charts in the world will not be able to predict her actions and the timing of her actions, and the potency of the news she releases.
Whether TA works in other situations, this is certainly a situation where it does not. It will never be able to predict WHEN she will release TLD. Mind you, it might predict price movement in the meantime until TLD for example, as that is a product of the market and the actions of many investors in the meantime - so long as LP does not issue news. But IMHO WHEN she will issue such news is beyond TA - a TA layman's thoughts on the matter.
But keep on predicting, sooner or later, you will be right - I HOPE.
Thanks DD
3. The trial yields great results.
Is there an archival recording of this Zoom meeting?
Thanks Jerry.
Could it be that NWBO is waiting for the final publication by the FDA OF the guidelines that they hope will in fact further clarify more of the details on the selection and assembly of an external control?
Could anyone discuss and elaborate on what these "challanges" to assembling an external control arm might look like.
I was kidding of course. No minions here - just little old me.
You must have good minions. My minions have NOT been happy with me of late!
Your email says differently!
Well pretty much all of those who may have recently loaned money to the company would have signed NDAs first, then been told the material information, then had the option to loan funds to the company or not. The only provision of the NDA, either way, would probably be that they could no longer buy or sell shares in the market.